Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 54
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do lichens withstand desiccation?

    Lichens, symbioses between fungi and algae, survive levels of desiccation lethal to most organisms. We recently...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Can we increase human safety by understanding the language of bears?

    Fear of bears has gripped humans for centuries but no scientific effort has sought to understand how to...

    Backer Badge Funded